Reference is made to the stock exchange announcements issued by Hofseth BioCare ASA (the "Company", ticker "HBC") on 28 February 2013 and 1 March 2013. Notice is hereby given that an extraordinary general meeting of the Company for the purpose of issuing shares in the private placement will be held at Moloveien 6, in the municipality of Ålesund on 22 March at 12:00 CET and not on 21 March 2013 as stated in the previous stock exchange announcements issued 28 February 2013 and 1 March 2013.
The notice of the extraordinary general meeting and attendance/proxy forms are attached hereto.
The notice of the extraordinary general meeting and attendance/proxy forms are also available at www.hofsethbiocare.no.
For more information please contact:
Øystein Omvik, CFO Hofseth BioCare ASA
Tel: +47 9369 9400
Email: oystein.omvik@h-bc.no
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
The notice of the extraordinary general meeting and attendance/proxy forms are attached hereto.
The notice of the extraordinary general meeting and attendance/proxy forms are also available at www.hofsethbiocare.no.
For more information please contact:
Øystein Omvik, CFO Hofseth BioCare ASA
Tel: +47 9369 9400
Email: oystein.omvik@h-bc.no
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
